ATE477255T1 - Imidazobenzdiazepinderivate - Google Patents
ImidazobenzdiazepinderivateInfo
- Publication number
- ATE477255T1 ATE477255T1 AT06806921T AT06806921T ATE477255T1 AT E477255 T1 ATE477255 T1 AT E477255T1 AT 06806921 T AT06806921 T AT 06806921T AT 06806921 T AT06806921 T AT 06806921T AT E477255 T1 ATE477255 T1 AT E477255T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- imidazobenzdiazepine
- cognitive
- triazolo
- gaba
- Prior art date
Links
- KLNFAMGHSZQYHR-UHFFFAOYSA-N imidazo[4,5-i][1,2]benzodiazepine Chemical class C1=CC=NN=C2C3=NC=NC3=CC=C21 KLNFAMGHSZQYHR-UHFFFAOYSA-N 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 239000002475 cognitive enhancer Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- MEYXEJCDZRDIFZ-UHFFFAOYSA-N imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine Chemical class C=1N2N=CN=C2C2=CC=CC=C2N2CN=CC2=1 MEYXEJCDZRDIFZ-UHFFFAOYSA-N 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Lubricants (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05109446 | 2005-10-11 | ||
| PCT/EP2006/066960 WO2007042421A1 (en) | 2005-10-11 | 2006-10-02 | Imidazo benzodiazepine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE477255T1 true ATE477255T1 (de) | 2010-08-15 |
Family
ID=37638034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06806921T ATE477255T1 (de) | 2005-10-11 | 2006-10-02 | Imidazobenzdiazepinderivate |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7507729B2 (de) |
| EP (1) | EP1937688B1 (de) |
| JP (1) | JP4885967B2 (de) |
| KR (1) | KR101009860B1 (de) |
| CN (1) | CN101287738B (de) |
| AT (1) | ATE477255T1 (de) |
| AU (1) | AU2006301377B2 (de) |
| BR (1) | BRPI0617204A2 (de) |
| CA (1) | CA2625611A1 (de) |
| DE (1) | DE602006016147D1 (de) |
| ES (1) | ES2348356T3 (de) |
| IL (1) | IL190398A0 (de) |
| WO (1) | WO2007042421A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2913886B1 (fr) | 2007-03-22 | 2012-03-02 | Guerbet Sa | Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer |
| US8754113B2 (en) | 2009-12-15 | 2014-06-17 | Shionogi & Co., Ltd. | Oxadiazole derivative having endothelial lipase inhibitory activity |
| EP2457569A1 (de) | 2010-11-05 | 2012-05-30 | F. Hoffmann-La Roche AG | Verwendung aktiver pharmazeutischer Verbindungen zur Behandlung von Erkrankungen des zentralen Nervensystems |
| PH12013500676A1 (en) * | 2010-11-05 | 2013-05-06 | Hoffmann La Roche | Use of active pharmaceutical compounds for the treatment of central nervous system conditions |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| AU2014368961B2 (en) * | 2013-12-20 | 2019-10-17 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| EP3310785B1 (de) * | 2015-06-19 | 2024-11-20 | Agenebio, Inc. | Benzodiazepinderivate, zusammensetzungen und verfahren zur behandlung kognitiver beeinträchtigung |
| US11505555B2 (en) | 2016-12-19 | 2022-11-22 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| US20180170941A1 (en) | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| MX2020013927A (es) | 2018-06-19 | 2021-03-02 | Agenebio Inc | Derivados de benzodiazepina, composiciones y metodos para tratar el deterioro cognitivo. |
| CN113480447A (zh) * | 2021-07-14 | 2021-10-08 | 东莞理工学院 | 一种合成乳酰肼的方法 |
| WO2023083191A1 (zh) * | 2021-11-09 | 2023-05-19 | 四川大学华西医院 | 苯二氮卓类化合物及其制备方法和在医药上的用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146721A (en) | 1969-09-12 | 1979-03-27 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Pyrazol-4-acetic acid compounds |
| DE2940189A1 (de) | 1979-10-04 | 1981-04-16 | Basf Ag, 6700 Ludwigshafen | Isoxazolylcarbonsaeureanilide, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| ZA815961B (en) | 1980-08-27 | 1983-04-27 | Glaxo Group Ltd | Heterocyclic derivatives |
| EP0214158A1 (de) | 1985-02-11 | 1987-03-18 | The Upjohn Company | Pyridinyl-acylhydrazone mit anthelmintischer wirkung, verwendungsverfahren und arzneimittel |
| US5098920A (en) | 1990-05-04 | 1992-03-24 | G. D. Searle & Co. | 1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders |
| TW201311B (de) | 1991-06-17 | 1993-03-01 | Hoffmann La Roche | |
| JPH06242977A (ja) * | 1993-02-16 | 1994-09-02 | Mitsubishi Electric Corp | １チップマイクロプロセッサ |
| US5635103A (en) | 1995-01-20 | 1997-06-03 | The Procter & Gamble Company | Bleaching compositions and additives comprising bleach activators having alpha-modified lactam leaving-groups |
| US5656629A (en) | 1995-03-10 | 1997-08-12 | Sanofi Winthrop, Inc. | 6-substituted pyrazolo (3,4-d)pyrimidin-4-ones and compositions and methods of use thereof |
| DE19602505A1 (de) | 1996-01-25 | 1997-07-31 | Merck Patent Gmbh | 1-(Pyrazol-4-Indol-3-yl)-Piperidine |
| DE69910205T2 (de) | 1999-09-15 | 2004-06-17 | Agfa-Gevaert | Einen neuen Hydrazidtyp enthaltendes photographisches Material |
| TWI239333B (en) * | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
| US6686352B2 (en) * | 2001-05-18 | 2004-02-03 | Hoffmann-La Roche Inc. | Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives |
| GB2380190A (en) | 2001-08-28 | 2003-04-02 | Bayer Ag | Antiinflammatory heterocyclic sulphones |
| ATE402707T1 (de) * | 2004-10-12 | 2008-08-15 | Hoffmann La Roche | Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen |
| JP4751398B2 (ja) * | 2004-10-20 | 2011-08-17 | エフ．ホフマン−ラ ロシュ アーゲー | ハロゲン置換ベンゾジアゼピン誘導体 |
| NZ554439A (en) * | 2004-10-20 | 2009-09-25 | Hoffmann La Roche | Imidazo-benzodiazepine derivatives |
-
2006
- 2006-10-02 AU AU2006301377A patent/AU2006301377B2/en not_active Ceased
- 2006-10-02 EP EP06806921A patent/EP1937688B1/de not_active Not-in-force
- 2006-10-02 JP JP2008534985A patent/JP4885967B2/ja not_active Expired - Fee Related
- 2006-10-02 CN CN2006800379789A patent/CN101287738B/zh not_active Expired - Fee Related
- 2006-10-02 BR BRPI0617204-0A patent/BRPI0617204A2/pt not_active IP Right Cessation
- 2006-10-02 DE DE602006016147T patent/DE602006016147D1/de active Active
- 2006-10-02 ES ES06806921T patent/ES2348356T3/es active Active
- 2006-10-02 KR KR1020087010956A patent/KR101009860B1/ko not_active Expired - Fee Related
- 2006-10-02 CA CA002625611A patent/CA2625611A1/en not_active Abandoned
- 2006-10-02 AT AT06806921T patent/ATE477255T1/de active
- 2006-10-02 WO PCT/EP2006/066960 patent/WO2007042421A1/en not_active Ceased
- 2006-10-04 US US11/542,944 patent/US7507729B2/en not_active Expired - Fee Related
-
2008
- 2008-03-24 IL IL190398A patent/IL190398A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006016147D1 (en) | 2010-09-23 |
| IL190398A0 (en) | 2008-11-03 |
| KR20080063496A (ko) | 2008-07-04 |
| US20070082890A1 (en) | 2007-04-12 |
| AU2006301377B2 (en) | 2012-03-08 |
| BRPI0617204A2 (pt) | 2011-07-19 |
| US7507729B2 (en) | 2009-03-24 |
| CN101287738A (zh) | 2008-10-15 |
| WO2007042421A1 (en) | 2007-04-19 |
| JP2009511534A (ja) | 2009-03-19 |
| AU2006301377A1 (en) | 2007-04-19 |
| EP1937688B1 (de) | 2010-08-11 |
| JP4885967B2 (ja) | 2012-02-29 |
| EP1937688A1 (de) | 2008-07-02 |
| ES2348356T3 (es) | 2010-12-03 |
| CN101287738B (zh) | 2011-08-10 |
| CA2625611A1 (en) | 2007-04-19 |
| KR101009860B1 (ko) | 2011-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL190398A0 (en) | Imidazo benzodiazepine derivatives | |
| NO20071967L (no) | Imidazo-benzodiazepinderivater | |
| DK1869049T3 (da) | Imidazopyridazinforbindelser | |
| IL189762A0 (en) | Isoxazolo derivatives as gaba a alpha5 inverse agonists | |
| IL194947A0 (en) | Aryl-4-ethynyl-isoxazole derivatives | |
| TW200745121A (en) | Chemical compound | |
| IL190867A0 (en) | 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives | |
| DE60326060D1 (de) | Nichtvernetzende pyrroloä2,1-cüä1,4übenzodiazepine als potentielle antitumor-agentien und ihre herstellung | |
| MA29623B1 (fr) | Derives de pyrazolo [3, 4-d] azepine comme antagonistes d'histamine h3 | |
| TW200621716A (en) | Novel compounds | |
| ATE356127T1 (de) | Substituierte hexahydropyrrolo(1,2-a)pyrazine, octahydropyrido(1,2-a)pyrazine und decahydropyrazino(1,2-a)azepine | |
| TW200611701A (en) | Novel compounds | |
| MX2007004640A (es) | Derivados de benzodiazepina sustituidos con halogeno. | |
| TW200631953A (en) | Tetracyclic imidazo-benzodiazepines | |
| DK1742950T3 (da) | Pyrazolo-[4,3-D]-pyrimidiner | |
| GB2446080A (en) | A novel Pyrrolo [2,1-C][1,4] benzodiazepine hybrid and a process for the preparation thereof | |
| BRPI0606730A2 (pt) | derivados de fenil metanona 2,5-di-substituìdos como inibidores do transportador de glicina 1 (glyt-1) para o tratamento de distúbios neurológicos e neuropsiquiátricos | |
| MXPA06000774A (es) | E3-nitro-pirazolo[1,5-a]pirimidinas 7-sustituidas y composiciones y metodos relacionados. | |
| TH79587A (th) | อนุพันธ์ของอิมิดาโซ-เบนโซไดอะซีพีน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1937688 Country of ref document: EP |